Showing results (41-50 of 136) with videos related to
Sort By:
Pageof 14
Psychiatry (Edgmont (Pa. : Township))|September 4, 2009
Treatment of fibromyalgiaElisa F Cascade, Amir H Kalali, Nikhil D Nihalani, et al.CNS Spectrums|January 15, 2013
Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trialAndrew J Cutler, Amir H Kalali, Greg W Mattingly, et al.Journal of Medical Internet Research|October 13, 2012
Conducting research on the Internet: medical record data integration with patient-reported outcomesElisa Cascade, Paige Marr, Matthew Winslow, et al.Psychiatry (Edgmont (Pa. : Township))|July 11, 2012
Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I DisorderRichard H Weisler, Amir H Kalali, Andrew J Cutler, et al.Journal of Clinical Psychopharmacology|May 6, 2008
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophreniaAndrew J Cutler, Amir H Kalali, Peter J Weiden, et al.Psychiatry (Edgmont (Pa. : Township))|September 4, 2009
Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorderRichard H Weisler, Amir H Kalali, Andrew J Cutler, et al.Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
Use of Antipsychotics Pre- and Post-Dissemination of CATIE DataElisa F Cascade, Amir H Kalali, Jeffrey Lieberman, et al.CNS Spectrums|January 20, 2018
Converting oral to long-acting injectable antipsychotics: a guide for the perplexedJonathan M MeyerCNS Spectrums|May 29, 2014
A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettesJonathan M MeyerCurrent Topics in Behavioral Neurosciences|February 12, 2011
Antipsychotics and metabolics in the post-CATIE eraJonathan M MeyerPageof 14